182 related articles for article (PubMed ID: 20511614)
21. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.
Brijker F; Magee CC; Tervaert JW; O'Neill S; Walshe JJ
Clin Nephrol; 1999 Dec; 52(6):344-51. PubMed ID: 10604641
[TBL] [Abstract][Full Text] [Related]
22. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
23. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
Stone JH;
Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
[TBL] [Abstract][Full Text] [Related]
25. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
26. [Wegener's granulomatosis: a report of 6 patients].
Tural C; Cuxart A; Bertrán X; Puigdengoles X; Segura A; Rey-Joly C
Med Clin (Barc); 1992 Jun; 99(2):63-6. PubMed ID: 1630183
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
Ye H; Gao Y; Guo XH; Zhao MH
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
[TBL] [Abstract][Full Text] [Related]
28. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
Finkielman JD; Lee AS; Hummel AM; Viss MA; Jacob GL; Homburger HA; Peikert T; Hoffman GS; Merkel PA; Spiera R; St Clair EW; Davis JC; McCune WJ; Tibbs AK; Ytterberg SR; Stone JH; Specks U;
Am J Med; 2007 Jul; 120(7):643.e9-14. PubMed ID: 17602941
[TBL] [Abstract][Full Text] [Related]
29. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
Stegeman CA; Tervaert JW; de Jong PE; Kallenberg CG
N Engl J Med; 1996 Jul; 335(1):16-20. PubMed ID: 8637536
[TBL] [Abstract][Full Text] [Related]
30. Wegener's granulomatosis: the relationship between ocular and systemic disease.
Harper SL; Letko E; Samson CM; Zafirakis P; Sangwan V; Nguyen Q; Uy H; Baltatzis S; Foster CS
J Rheumatol; 2001 May; 28(5):1025-32. PubMed ID: 11361183
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
Takizawa M
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
34. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R; Ljevak M; Vikgren J; Bokarewa M
Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
[TBL] [Abstract][Full Text] [Related]
35. Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides.
Terrier B; Saadoun D; Sène D; Ghillani P; Amoura Z; Deray G; Fautrel B; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Oct; 68(10):1564-71. PubMed ID: 18957481
[TBL] [Abstract][Full Text] [Related]
36. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
Reinhold-Keller E; Fink CO; Herlyn K; Gross WL; De Groot K
Arthritis Rheum; 2002 Jun; 47(3):326-32. PubMed ID: 12115164
[TBL] [Abstract][Full Text] [Related]
37. Wegener's granulomatosis in patients with rheumatoid arthritis.
Douglas G; Bird K; Flume P; Silver R; Bolster M
J Rheumatol; 2003 Sep; 30(9):2064-9. PubMed ID: 12966617
[TBL] [Abstract][Full Text] [Related]
38. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
39. [A child with Wegener's granulomatosis].
Spronk MH; Pals ST; Haumann TJ; Schouten-van Meeteren AY
Tijdschr Kindergeneeskd; 1992 Apr; 60(2):52-6. PubMed ID: 1641847
[TBL] [Abstract][Full Text] [Related]
40. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
